I can understand why you are thinking that way about this stock, however, you need to know that this stock had a run, on its run. The difference is that the last run was done on false pretense of Prop 19 having a significant effect on the profitability of the company.....many who bought in prior to Prop 19 did not really know what the company actually did. So when Prop 19 failed, many dumped and took their loss or some might have sold just prior for profit.
I myself have been in this thing for a while....I acumilated a good amount of shares right at this level just before the Prop 19 push and sold half two days prior to the vote. But you have to understand that this is a Medical Marijuana play. It should be treated as any other biotec that designs new drug treatments. Some it and some miss, however, we on the other hand do grow and sell in states where Med. Marijuana is approved and that number is growing each year......when FDA trials are approved for there drug to treat PTSD....then we will have an exclusive on that $2Billion industry alone.....bottomline, this is a long term play with some huge upside potential.....Divy release will boost it some, but the real money will be made when they announce the FDA trials.....good luck
